drugset / Trial / NCT02676713

Summary

Endometriosis is a common, chronic disease. 30% to 50% of women with endometriosis are infertile. There is moderate quality evidence that laparoscopic surgery to treat mild and moderate endometriosis increases live birth or ongoing pregnancy rates. There was no evidence of benefit for post-surgical hormonal suppression of endometriosis compared to surgery alone for the outcomes of pregnancy rates. Past studies have confirmed that Chinese herbal medicine can inhibit post-surgical endometriosis recurrence, increase pregnancy rate.This study evaluates the efficacy and safety of Traditional Chinese Medicine Sequential Treatment of endometriosis-associated infertility. The study objective is to confirm that clinical pregnancy rate of patients with endometriosis-associated infertility post-conservative surgery accepting Chinese medicine activating blood, dredging liver and nourishing kidney sequential treatment is higher than expectant treatment.

Timeline

Start
2014-12
Primary completion
2017-05
Completion
2017-12

Outcome

Met primary endpoint

paper the clinical pregnancy and live birth rates of the CM group were significantly higher than those of the placebo group [44.6% (45/101) vs. 29.7% PMID 31997236 ↗

paper both P<0.05 PMID 31997236 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject BuShenZhuYun Decoction Unknown 2 unknown —
Subject HuoXueXiaoYi Decoction Traditional medicine (herbal / TCM) 2 unknown —